Supplemental material
Acta Oncologica
Volume 62, 2023 - Issue 12
Original Articles: Cancer Epidemiology
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017
Mette K. Thomsena Department of Oncology, Cancer Survivorship and Treatment Late effects CASTLE group, Copenhagen, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0001-7308-3431
https://orcid.org/0000-0001-7308-3431, Katrine B. Løppenthinb Department of Oncology, Copenhagen, Denmarkhttps://orcid.org/0000-0003-3074-4265
https://orcid.org/0000-0003-3074-4265, Pernille E. Bidstrupc Danish Cancer Society Research Center, Copenhagen, Denmarkhttps://orcid.org/0000-0002-9704-6800
https://orcid.org/0000-0002-9704-6800, , Susanne Daltonc Danish Cancer Society Research Center, Copenhagen, Denmarkhttps://orcid.org/0000-0002-5485-2730
https://orcid.org/0000-0002-5485-2730, , Helle Pappotb Department of Oncology, Copenhagen, Denmarkhttps://orcid.org/0000-0002-3570-5372
https://orcid.org/0000-0002-3570-5372, , Mikkel B. Christensend Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark;e Copenhagen Center for Translational Research, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmarkhttps://orcid.org/0000-0002-8774-1797
https://orcid.org/0000-0002-8774-1797, , Ulrik Lassenb Department of Oncology, Copenhagen, Denmarkhttps://orcid.org/0000-0002-3865-4574
https://orcid.org/0000-0002-3865-4574 & Christoffer Johansena Department of Oncology, Cancer Survivorship and Treatment Late effects CASTLE group, Copenhagen, Denmark;b Department of Oncology, Copenhagen, Denmarkhttps://orcid.org/0000-0002-4384-206X
https://orcid.org/0000-0002-4384-206X show all